INC.

Minghui Pharmaceutical Inc. Announces First Patient Dosing in Phase 1 Clinical Studies of Both the Antibody-Drug Conjugate Programs Targeting TROP-2 or B7-H3 Respectively, for Treatment of Advanced or Metastatic Solid Tumors

by

SHANGHAI and HANGZHOU, China and WILMINGTON, Del., June 20, 2023 /PRNewswire/ — Minghui Pharmaceutical, Inc., a leading clinical-stage biopharmaceutical company, announced today that the first dosing has been completed in two phase 1 clinical studies evaluating MHB036C and MHB088C. The studies aim to determine the maximum tolerated dose (MTD), the recommended phase 2 dose (RP2D), … Read more

Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program

by

— FDA has provided clearance to the company to continue dosing patients who have already undergone lymphodepletion — REDWOOD CITY, Calif., June 19, 2023 /PRNewswire/ — Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, announced today that it has … Read more

Avanos Medical, Inc. Announces Agreement to Acquire Diros Technology Inc.

by

Unique tined-probe technology further differentiates Avanos portfolio ALPHARETTA, Ga., June 19, 2023 /PRNewswire/ — Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to acquire Diros Technology Inc., a leading manufacturer of innovative radiofrequency (RF) products used to treat chronic pain conditions. Based in Toronto, Canada, Diros Technology has been … Read more

Novavax est prêt à fournir un vaccin monovalent protéinique contre le virus XBB COVID conformément à la recommandation du VRBPAC de la FDA pour l’automne USA – Français USA – English APAC – English USA – Deutsch USA – español USA – English USA – English APAC – English

by

Novavax a développé un vaccin candidat monovalent protéinique contre le virus XBB.1.5 COVID et le produit à l’échelle commerciale avec l’intention de le lancer sur le marché lors de la campagne de vaccination prévue à l’automne Novavax a partagé des données démontrant que son vaccin candidat XBB.1.5 COVID induit des réponses immunitaires fonctionnelles aux sous-variants … Read more

Millar Steers PV Loop Technology and Customers into the Future by Combining Market Leading Catheter Solutions with Transonic Scisense Systems

by

HOUSTON, June 19, 2023 /PRNewswire/ — Millar, the industry leader in research pressure measurements and global OEM solutions partner, announces that it will be guiding pressure-volume (PV) loop technology into the future by combining its market-leading catheter solutions with Transonic Scisense’s Admittance-based pressure-volume (PV) loop systems. To support Transonic Scisense’s exit from the life sciences … Read more

Nippon Express Europe a participé pour la première fois à LogiPharma 2023

by

TOKYO, 19 juin 2023 /PRNewswire/ — Nippon Express Europe GmbH, une société du groupe NIPPON EXPRESS HOLDINGS, INC., a participé pour la première fois au salon LogiPharma 2023 qui s’est tenu à Lyon, en France, du mardi 25 avril au jeudi 27 avril. Logo : https://kyodonewsprwire.jp/img/202306136298-O1-VPF88v28 Photo : https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg? _ga=2.3372912.1997240702.1686531031-1438572707.1685531252 LogiPharma 2023 est l’un des plus grands salons pharmaceutiques internationaux, axé sur les … Read more

Nippon Express Europe stellt 2023 erstmals auf der LogiPharma aus

by

TOKIO, 19. Juni 2023 /PRNewswire/ — Die Nippon Express Europe GmbH, ein Konzernunternehmen von Nippon Express Holdings, Inc., stellte auf der „LogiPharma 2023″ erstmals auf der Messe aus, die von Dienstag, 25. April, bis Donnerstag, 27. April, in Lyon, Frankreich, stattfand. Logo: https://kyodonewsprwire.jp/img/202306136298-O1-VPF88v28 Foto: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg?_ga=2.3372912.1997240702.1686531031-1438572707.1685531252 Die LogiPharma 2023 ist eine der weltweit größten internationalen Fachmessen … Read more

Nippon Express Europe expone en LogiPharma 2023 por primera vez

by

TOKIO, 15 de junio de 2023 /PRNewswire/ — Nippon Express Europe GmbH, empresa del grupo NIPPON EXPRESS HOLDINGS, INC., expuso por primera vez en “LogiPharma 2023” celebrada en Lyon, Francia, del martes 25 al jueves 27 de abril. Logo: https://kyodonewsprwire.jp/img/202306136298-O1-VPF88v28 Foto: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg?_ga=2.3372912.1997240702.1686531031-1438572707.1685531252 LogiPharma 2023 es una de las ferias comerciales farmacéuticas internacionales más grandes del mundo, que … Read more

Cano Health Announces Leadership Change to Advance Execution of Value Creation Plan

by

Mark Kent appointed Interim Chief Executive Officer Dr. Marlow Hernandez has agreed to step down immediately as Chief Executive Officer and remain on the Board of Directors Launches search to identify permanent CEO and to refresh the Board with additional new independent directors MIAMI, June 16, 2023 /PRNewswire/ — Cano Health, Inc. (“Cano Health” or … Read more

Healthcare Trust Announces Preferred Stock Dividends

by

NEW YORK, June 16, 2023 /PRNewswire/ — Healthcare Trust, Inc. (Nasdaq: HTIA / HTIBP) (“HTI”) announced today that it declared quarterly dividends on its outstanding preferred stock. Specifically, HTI declared a dividend of $0.4609375 per share on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) payable on July 17, … Read more